Document is current
Any future updates will be listed below
-
Authors
Barraza-Flores, Pamela
Moghadaszadeh, Behzad
Lee, Won
Isaac, Biju
Sun, Liang
Hickey, Emily T.
Rockowitz, Shira
Sliz, Piotr
Beggs, Alan H. https://orcid.org/0000-0001-8818-0568
-
Funding
Funding for this research was provided by:
Lee and Penny Anderson Family Foundation
Jonathan and Deborah Parker and the Giving Strength Fund
Muscular Dystrophy Association
Eunice Kennedy Shriver National Institute of Child Health and Human Development (P50HD105351)
National Institute of Neurological Disorders and Stroke (T32NS007473)
- License Information
-
More Information
Article History
Received: 13 August 2024
Accepted: 25 February 2025
First Online: 15 March 2025
Declarations
:
: AHB receives consulting income from Kate Therapeutics, Astellas Pharma, Roche Pharmaceuticals, GLG Inc, and Guidepoint Global, and has equity in Kate Therapeutics and Kinea Bio. For all other authors no competing interests are declared.
